BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Heart
,
DNA fingerprint
,
Acetaminophen
,
rs2300478
,
PBX1
,
Fatty acid metabolic process
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
IL 3
Summary
General Info
Curated Studies
Most Correlated Studies
Primary acute myeloid leukemia cells treated with IL-3
Progenitor B BaF3 cells with DOX-induced BCR-ABL expression in the presence or absence of IL-3
Myeloid 32D cell line overexpressing miR-9/9* and treated with IL-3
T regulatory cells treated with IFN-gamma or IL-27
Interleukin IL-6 and IL-11 responsive genes in murine gastric tumors
Explore Curated Studies Results
Literature
Most Relevant Literature
IL-3: key orchestrator of inflammation.
Interleukin 3 Inhibits Glutamate-Cytotoxicity in Neuroblastoma Cell Line.
E3 ubiquitin ligase RNF128 negatively regulates the IL-3/STAT5 signaling pathway by facilitating K27…
IL-3 receptor signalling suppresses chronic intestinal inflammation by controlling mechanobiology an…
IL-3 Expands Pre-Basophil and Mast Cell Progenitors by Upregulating the IL-3 Receptor Expression.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase I Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Plus GM-CSF (Granulocyte-Mac…
Tagraxofusp-erzs, an IL-3 Diphtheria Fusion Protein, in Combination With Gemtuzumab Ozogamicin in Pa…
Study of MAGE-3/Melan-A/gp 100/NA17 and rhIL-12 With/Out Low Dose IL-2 in Metastatic Melanoma
A Phase I, Open Label Trial to Evaluate the Safety, Tolerance and Biological Effects of SDZ ILE-964 …
A Phase 3 Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants Wit…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ